Subcutaneous Immunotherapy: It Is Time for Real-World Data
JCO Oncology Practice · 2026-06 · 22 (6) · 1137-1138
DOI: 10.1200/op-26-00070 ↗Kurz gefasst
Leserbrief in der Zeitschrift JCO Oncology Practice, 2026-06. Verfasst von Daniel Sentana-Lledo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Daniel Sentana-Lledo, MD, Dana-Farber Cancer Institute, Boston, MA; and Arjun Gupta, MD, City of Hope Cancer Center Phoenix, Phoenix, AZ. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Daniel Sentana-Lledo, MD, Dana-Farber Cancer Institute, Boston, MA; and Arjun Gupta, MD, City of Hope Cancer Center Phoenix, Phoenix, AZ.
ORCID-Profile: Daniel Sentana-Lledo, Arjun Gupta
Zitieren
APA
Sentana-Lledo, D., & Gupta, A. (2026). Subcutaneous Immunotherapy: It Is Time for Real-World Data. JCO Oncology Practice, 22(6), 1137-1138. https://doi.org/10.1200/op-26-00070
Vancouver
Sentana-Lledo D, Gupta A. Subcutaneous Immunotherapy: It Is Time for Real-World Data. JCO Oncology Practice. 2026;22(6):1137-1138. doi:10.1200/op-26-00070
BibTeX
@article{SentanaLledo2026,
author = {Sentana-Lledo, Daniel and Gupta, Arjun},
title = {Subcutaneous Immunotherapy: It Is Time for Real-World Data},
journal = {JCO Oncology Practice},
year = {2026},
volume = {22},
number = {6},
pages = {1137--1138},
doi = {10.1200/op-26-00070}
}
EUVIMED